Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin for Pelvic Pain in Endometriosis
NCT01553201Phase 2Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Jul 2014
- Primary completion
- Jul 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in chronic pelvic pain (CPP), Pelvic floor muscle spasm (PFD), sponsored by National Institute of Neurological Disorders and Stroke. Started Jul 2014; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
chronic pelvic pain (CPP)Pelvic floor muscle spasm (PFD)
Beyond the preview
Go deeper on NCT01553201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01553201.